New semaglutide manufacturing process tested in diabetes patients
NCT ID NCT05478252
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new way of making semaglutide works as well as the current version for controlling blood sugar in people with type 2 diabetes. 388 participants received weekly injections for about 8 months. The main goal was to compare changes in HbA1c levels between the two groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
388 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Sep 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with type 2 diabetes (T2D) mellitus greater than equal to (≥) 180 days before screening. * Stable daily dose(s) ≥ 90 days prior to the day of screening of metformin ≥ 1500 milligrams (mg) or maximum tolerated or effective dose. * HbA1c of 7.0-10.5 percentage (%) \[53-91.3 millimoles per mole (mmol/mol)\] (both inclusive). Exclusion Criteria: * Known or suspected hypersensitivity to study intervention(s) or related products. * Treatment with any medication for the indication of diabetes or obesity other than stated in the inclusion criteria within 90 days before screening. However, short term insulin treatment for a maximum of 14 days and prior insulin treatment for gestational diabetes are allowed. * Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for nondilated examination.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Adult Medicine of Lake County, Inc.
Mt. Dora, Florida, 32757, United States
-
Advanced Med Res Maumee
Maumee, Ohio, 43537, United States
-
Albert J Weisbrot
Mason, Ohio, 45040-6815, United States
-
Alliance for Multispec Res
Coral Gables, Florida, 33134, United States
-
Arcturus Healthcare, PLC.
Troy, Michigan, 48098, United States
-
BTC of New Bedford, LLC
New Bedford, Massachusetts, 02740, United States
-
Beata Miklaszewicz&Dariusz Dabrowski "CARDIAMED" s.j.
Legnica, Lower Silesian Voivodeship, 59-220, Poland
-
Bluewater Clin Res Group,Inc
Sarnia, Ontario, N7T 4X3, Canada
-
CVS Store Number: 01396
Reston, Virginia, 20191-4327, United States
-
CVS Store Number: 05520
Savannah, Georgia, 31405-6901, United States
-
CVS Store Number: 1537
Richmond, Virginia, 23230-3005, United States
-
CVS Store Number: 7689
Atlanta, Georgia, 30329-4015, United States
-
Canadian Centre for Research on Diabetes_Smiths Falls
Smiths Falls, Ontario, K7A 4W8, Canada
-
Care Clinic
Red Deer, Alberta, T4P 1K4, Canada
-
Centricity Res Pointe-Claire
Pointe-Claire, Quebec, H9R 4S3, Canada
-
Centricity Research Brampton
Brampton, Ontario, L6S 0C6, Canada
-
Centricity Research Etobicoke
Etobicoke, Ontario, M9R 4E1, Canada
-
Centricity Research New Minas
New Minas, Nova Scotia, B4N 3R7, Canada
-
Centricity Research Ville St. Laurent VSL
Saint-Laurent, Quebec, H4T 1Z9, Canada
-
Centrum Medyczne "Diabetika"
Radom, 26-600, Poland
-
Clin Invest Spec, Inc
Wauconda, Illinois, 60084, United States
-
Clinical Trial Systems (CTC)
Pretoria, Gauteng, 0186, South Africa
-
DIA - SANTMART, s.r.o., Ambulancia diabetologie a poruch latkovej premeny a vyzivy
Martin, 036 01, Slovakia
-
Diabetologicka ambulancia DIAMO s.r.o.
Kežmarok, 06001, Slovakia
-
Diabetologicka ambulancia DIASTYLE s.r.o.
Banská Bystrica, 97401, Slovakia
-
Diabetologicka ambulancia MUDr. Iveta Markova s.r.o
Nitra, 94911, Slovakia
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Dr A Amod
Durban, KwaZulu-Natal, 4092, South Africa
-
Dr Pillay's Rooms
Durban, KwaZulu-Natal, 4450, South Africa
-
Dwayne O. Williams, M.D., P.A.
Sugar Land, Texas, 77479, United States
-
ETG Lublin
Lublin, Lublin Voivodeship, 20-412, Poland
-
ETG Lublin
Lublin, 20-412, Poland
-
Elite Clinical Trials
Blackfoot, Idaho, 83221, United States
-
Elite Research Center
Flint, Michigan, 48532, United States
-
Elligo Clin Res Centre
Austin, Texas, 78704, United States
-
Encompass Clinical Research_Spring Valley
Spring Valley, California, 91978, United States
-
Encore Medical Research LLC
Hollywood, Florida, 33024, United States
-
FDRC
Costa Mesa, California, 92627, United States
-
FutureMeds Sp. z o.o.
Wroclaw, 50-088, Poland
-
FutureMeds Sp. z o.o. Lodz
Lodz, 91-363, Poland
-
G.A. Research Associates Ltd.
Moncton, New Brunswick, E1G 1A7, Canada
-
IVAMEDIC s.r.o.
Košice, 040 11, Slovakia
-
Innovative Research of W FL
Clearwater, Florida, 33756, United States
-
Innovative Research of W Florida Inc.
Clearwater, Florida, 33756, United States
-
International Research Associates, LLC_Miami
Miami, Florida, 33183, United States
-
Jongaie Research
Pretoria, Gauteng, 0183, South Africa
-
Krakowskie Centrum Medyczne Sp. z o.o.
Krakow, 31-501, Poland
-
LCGK Research
San Carlos, California, 94070, United States
-
LMC Clin Res Inc. Thornhill
Concord, Ontario, L4K 4M2, Canada
-
LMC Clin Rsrch Inc. (Montreal)
Montreal, Quebec, H4T 1Z9, Canada
-
LMC Endo Centres Ltd.(Bayview)
Toronto, Ontario, M4G 3E8, Canada
-
LMC Manna Research
Toronto, Ontario, M4G 3E8, Canada
-
M2M Badania Kliniczne
Chorzów, 41-500, Poland
-
MD Medical Research
Oxon Hill, Maryland, 20745, United States
-
MEDI-DIA s.r.o.
Sabinov, 08301, Slovakia
-
MUDr. Jan Culak, s.r.o.
Prievidza, 97101, Slovakia
-
Macoupin Research Group
Gillespie, Illinois, 62033, United States
-
Manna Research Inc.
Pointe-Claire, Quebec, H9R 4S3, Canada
-
Manna Research Quebec
Lévis, Quebec, G6W 0M5, Canada
-
Martin Diagnostic Clinic
Tomball, Texas, 77375, United States
-
Med Partners, Inc.
Toluca Lake, California, 91602, United States
-
Medi-Clinic Bloemfontein
Bloemfontein, Free State, 9301, South Africa
-
Medical Trust Clinics, Inc.
Courtice, Ontario, L1E2J5, Canada
-
Milestone Research
London, Ontario, N5W 6A2, Canada
-
Montana Medical Research
Missoula, Montana, 59808, United States
-
Moriana Clinical Research
Winnie Mandela, Free State, 9400, South Africa
-
N.Y. Family Practice Physicians
Woodhaven, New York, 11421, United States
-
NZOZ Gdanska Poradnia Cukrzycowa Sp.z o.o.
Gdansk, 80-858, Poland
-
NZOZ Specjalistyczny Osrodek Internistyczno-Diabetologiczny Małgorzata Arciszewska
Bialystok, 15-435, Poland
-
New Horizon Research Center
Miami, Florida, 33165, United States
-
Nova Scotia Hlth Halifax
Halifax, Nova Scotia, B3H 2Y9, Canada
-
Ocean West Research Clinic
Surrey, British Columbia, V3Z 2N6, Canada
-
Omega Research Consultants LLC
Orlando, Florida, 32806, United States
-
Osteo Medic s.c. Artur Racewicz Jerzy Supronik
Bialystok, 15-351, Poland
-
PANSTWOWY INSTYTUT MEDYCZNY MSWiA
Warsaw, 02-507, Poland
-
PharmQuest Life Sciences LLC
Greensboro, North Carolina, 27408, United States
-
Precise Clinical Solutions (Pty) Ltd
Durban, KwaZulu-Natal, 4092, South Africa
-
Prime Medical Group, LLC
Gilbert, Arizona, 85296, United States
-
Prinshof Medical Campus
Pretoria, Gauteng, 0002, South Africa
-
Progressive Medical Research
Port Orange, Florida, 32127, United States
-
Recherche GCP Research
Montreal, Quebec, H1Y 3H5, Canada
-
Reyes Clinical Research, Inc
Miami, Florida, 33175, United States
-
San Diego Family Care_San Diego
San Diego, California, 92111, United States
-
Shop#1 Health Emporium
Midrand, Gauteng, 1685, South Africa
-
Solaris Clinical Research
Meridian, Idaho, 83646, United States
-
South Broward Research LLC
Miramar, Florida, 33027, United States
-
South Broward Research LLC
Pembroke Pines, Florida, 33027, United States
-
Southwest Clinical Trials
Houston, Texas, 77081, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
Sugar Lakes Family Practice PA
Sugar Land, Texas, 77479, United States
-
Tapia Internal Medicine Clinic
Paris, Texas, 75462, United States
-
The Research Group of Lexington LLC
Lexington, Kentucky, 40503, United States
-
Tristar Clin Investigations, PC
Philadelphia, Pennsylvania, 19114, United States
-
UT Southwestern Med Cntr
Dallas, Texas, 75390-9302, United States
-
Univ Of Texas Hlth Science Cntr
San Antonio, Texas, 78229, United States
-
University Clin Investigators
Tustin, California, 92780, United States
-
VIP Trials
San Antonio, Texas, 78230, United States
-
VIP Trials_San Antonio
San Antonio, Texas, 78230, United States
-
Velocity Clin Res Los Angeles
Los Angeles, California, 90017, United States
-
Velocity Clinical Res-Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research San Diego
La Mesa, California, 91942, United States
-
Wenatchee Valley Hospital and Clinics
Wenatchee, Washington, 98801-2028, United States
-
Wharton Med Clin Trials
Hamilton, Ontario, L8L 5G8, Canada
-
Whiteville Medical Assoc, PA
Whiteville, North Carolina, 28472, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effectiveness of shared decision Making(SDM)on patients with poor control type 2 diabetes
- A placebo-controlled, proof-of-concept study to evaluate the safety and efficacy of lanifibranor alone and in combination with the sodium-glucose transport protein 2 (SGLT2) inhibitor EmpaGliflozin in patiEnts with non-alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM)
- Blood tests may reveal hidden healing power of bone marrow stem cells
- A Finger-Prick at the pharmacy could uncover silent diabetes
- Can a simple fish help tame type 2 diabetes?
- Can text messages help younger latinx adults tame type 2 diabetes?